dc.contributor.author | Thompson, Dawn | |
dc.contributor.author | Morrice, Nicola | |
dc.contributor.author | Grant, Louise | |
dc.contributor.author | Le Sommer, Samantha | |
dc.contributor.author | Lees, Emma K | |
dc.contributor.author | Mody, Nimesh | |
dc.contributor.author | Wilson, Heather M | |
dc.contributor.author | Delibegovic, Mirela | |
dc.date.accessioned | 2017-09-29T09:00:12Z | |
dc.date.available | 2017-09-29T09:00:12Z | |
dc.date.issued | 2017-10-01 | |
dc.identifier.citation | Thompson , D , Morrice , N , Grant , L , Le Sommer , S , Lees , E K , Mody , N , Wilson , H M & Delibegovic , M 2017 , ' Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis ' , Clinical Science , vol. 131 , no. 20 , pp. 2489-2501 . https://doi.org/10.1042/CS20171066 | en |
dc.identifier.issn | 0143-5221 | |
dc.identifier.other | PURE: 107822984 | |
dc.identifier.other | PURE UUID: e9dc3ac0-47a1-4f02-bcec-66716c56a8be | |
dc.identifier.other | Scopus: 85031014506 | |
dc.identifier.other | ORCID: /0000-0003-3301-7397/work/60546621 | |
dc.identifier.other | ORCID: /0000-0002-2215-7952/work/36967463 | |
dc.identifier.other | ORCID: /0000-0003-0948-9458/work/77366287 | |
dc.identifier.other | ORCID: /0000-0002-1407-7274/work/83704340 | |
dc.identifier.uri | http://hdl.handle.net/2164/9373 | |
dc.description | The authors wish to thank Professor Nicholas Tonks for providing the PTP1B inhibitor trodusquemine; Linda Robertson for her help with the aorta histology; Dr Fiona Grieg for tuition into aortic dissection and Dr James Hislop for critical reading of this manuscript. We also wish to thank the British Heart Foundation (PG/14/43/30889) for supporting this research | en |
dc.format.extent | 13 | |
dc.language.iso | eng | |
dc.relation.ispartof | Clinical Science | en |
dc.rights | © 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | protein tyrosine phosphatases | en |
dc.subject | metabolic syndromes | en |
dc.subject | atherosclerosis | en |
dc.subject | R Medicine | en |
dc.subject | British Heart Foundation | en |
dc.subject | PG/14/43/30889 | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1042/CS20171066 | |
dc.identifier.vol | 131 | en |
dc.identifier.iss | 20 | en |